Dimensional Fund Advisors’s Denali Therapeutics DNLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$33.8M Buy
2,412,928
+312,072
+15% +$4.37M 0.01% 1714
2025
Q1
$28.6M Buy
2,100,856
+245,820
+13% +$3.34M 0.01% 1774
2024
Q4
$37.8M Buy
1,855,036
+295,594
+19% +$6.02M 0.01% 1684
2024
Q3
$45.4M Buy
1,559,442
+141,970
+10% +$4.14M 0.01% 1562
2024
Q2
$32.9M Buy
1,417,472
+84,522
+6% +$1.96M 0.01% 1702
2024
Q1
$27.4M Buy
1,332,950
+213,322
+19% +$4.38M 0.01% 1828
2023
Q4
$24M Buy
1,119,628
+146,394
+15% +$3.14M 0.01% 1894
2023
Q3
$20.1M Buy
973,234
+218,433
+29% +$4.51M 0.01% 1916
2023
Q2
$22.3M Buy
754,801
+127,476
+20% +$3.76M 0.01% 1881
2023
Q1
$14.4M Buy
627,325
+69,067
+12% +$1.59M ﹤0.01% 2063
2022
Q4
$15.5K Sell
558,258
-51,581
-8% -$1.43K ﹤0.01% 1988
2022
Q3
$18.7M Sell
609,839
-281,839
-32% -$8.65M 0.01% 1873
2022
Q2
$26.2M Buy
891,678
+13,454
+2% +$396K 0.01% 1708
2022
Q1
$28.3M Buy
878,224
+106,027
+14% +$3.41M 0.01% 1788
2021
Q4
$34.4M Buy
772,197
+137,462
+22% +$6.13M 0.01% 1670
2021
Q3
$32M Buy
634,735
+309,387
+95% +$15.6M 0.01% 1743
2021
Q2
$25.5M Sell
325,348
-95,854
-23% -$7.52M 0.01% 1934
2021
Q1
$24M Sell
421,202
-31,578
-7% -$1.8M 0.01% 1946
2020
Q4
$37.9M Sell
452,780
-82,339
-15% -$6.9M 0.01% 1587
2020
Q3
$19.2M Sell
535,119
-15,578
-3% -$558K 0.01% 1876
2020
Q2
$13.3M Sell
550,697
-13,162
-2% -$318K 0.01% 2081
2020
Q1
$9.88M Buy
563,859
+42,193
+8% +$739K 0.01% 2126
2019
Q4
$9.09M Buy
521,666
+123,343
+31% +$2.15M ﹤0.01% 2388
2019
Q3
$6.1M Buy
398,323
+193,781
+95% +$2.97M ﹤0.01% 2536
2019
Q2
$4.25M Buy
+204,542
New +$4.25M ﹤0.01% 2690